Details for New Drug Application (NDA): 020750
✉ Email this page to a colleague
NDA 020750 describes TILADE, which is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in two NDAs. Additional details are available on the TILADE profile page.
The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
The generic ingredient in TILADE is nedocromil sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the nedocromil sodium profile page.
Summary for 020750
| Tradename: | TILADE |
| Applicant: | Sanofi Aventis Us |
| Ingredient: | nedocromil sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020750
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INHALATION | Strength | 0.5% | ||||
| Approval Date: | Oct 1, 1997 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
